drugset / Trial / NCT06597344

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

NCT06597344

Phase 3 Completed 97 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

The study will be conducted to evaluate the clinical symptom improvement and safety of oral gepotidacin for treatment of uncomplicated UTI (acute cystitis) in adolescent and adult female participants.

Timeline

Start
2024-10-02
Primary completion
2025-03-10
Completion
2025-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gepotidacin Small molecule Oral